dorsaVi completes clinical study with Norton Healthcare

dorsaVi (ASX: $DVL) has successfully completed the data collection and analysis for a clinical study with Norton Healthcare, generating approximately A$100,000 in sponsored research support over a 24-month period. The study focused on investigating spinal motion and patterns of movement pre and post surgery, leveraging dorsaVi's wearable sensor technology and advanced AI and Machine Learning algorithms.

Executive Commentary on Collaboration and Study Findings

We are extremely proud of the collaboration with such a well-respected institution. We are honoured to work with Dr. Steven Glassman, one of the leading experts in spinal surgery, and whose research is at the forefront of the sector. I am excited that our technology will help generate new insights into patterns of movement and potentially improve outcomes for patients with spinal conditions. We will continue to strive to work with top-tier institutions to deliver value to our shareholders.

Summary of Clinical Study and Future Prospects

dorsaVi (ASX: $DVL) has successfully concluded a clinical study with Norton Healthcare, reinforcing its position as a leading provider of wearable sensor technology. The collaboration with Dr. Steven Glassman and the Norton Research Institute has not only enhanced dorsaVi's top-tier client base but also diversified its revenue stream. The study's findings, expected to be published in peer-reviewed journals and discussed at medical conferences, are anticipated to provide valuable insights into patient movement, particularly in the context of spinal conditions. This achievement aligns with dorsaVi's goal of delivering value to its shareholders and further solidifying its position in the clinical and occupational health and safety markets.